Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A clinical diagnosis of one of the following: low-back pain of non-malignant origin for at least 3 months, osteoarthritis of the knee or hip for at least 3 months~* require daily doses of analgesia medication for chronic pain that is consistent with or makes them candidates for treatment at Step 2 or higher of the WHO Pain Relief Ladder~* post-washout baseline pain intensity score \>4 on an 11-point numerical rating scale~Exclusion Criteria:~* History of seizure disorder or epilepsy~* uncontrolled hypertension~* currently treated with monoamine oxidase inhibitors~* systemic steroid therapy, excluding inhalers or topical steroids, within 3 months before screening~* history of malignancy within the past 2 years, with the exception of basal cell carcinoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).